GB0507557D0 - Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions - Google Patents

Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions

Info

Publication number
GB0507557D0
GB0507557D0 GBGB0507557.7A GB0507557A GB0507557D0 GB 0507557 D0 GB0507557 D0 GB 0507557D0 GB 0507557 A GB0507557 A GB 0507557A GB 0507557 D0 GB0507557 D0 GB 0507557D0
Authority
GB
United Kingdom
Prior art keywords
deseases
autoimmune
compounds
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0507557.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TRINITY OF QUEEN ELIZABETH NEA
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
TRINITY OF QUEEN ELIZABETH NEA
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TRINITY OF QUEEN ELIZABETH NEA, College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin filed Critical TRINITY OF QUEEN ELIZABETH NEA
Priority to GBGB0507557.7A priority Critical patent/GB0507557D0/en
Publication of GB0507557D0 publication Critical patent/GB0507557D0/en
Priority to PCT/IE2006/000032 priority patent/WO2006109285A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
GBGB0507557.7A 2005-04-14 2005-04-14 Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions Ceased GB0507557D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0507557.7A GB0507557D0 (en) 2005-04-14 2005-04-14 Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions
PCT/IE2006/000032 WO2006109285A1 (en) 2005-04-14 2006-04-18 Methods and compounds for the treatment of autoimmune diseases and chronic inflammatory conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0507557.7A GB0507557D0 (en) 2005-04-14 2005-04-14 Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions

Publications (1)

Publication Number Publication Date
GB0507557D0 true GB0507557D0 (en) 2005-05-18

Family

ID=34611126

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0507557.7A Ceased GB0507557D0 (en) 2005-04-14 2005-04-14 Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions

Country Status (2)

Country Link
GB (1) GB0507557D0 (en)
WO (1) WO2006109285A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128628T1 (en) * 1990-08-13 1995-10-15 American Cyanamid Co FIBER HEMAGGLUTININ FROM BORDETELLA PERTUSSIS AS A CARRIER FOR CONJUGATE VACCINE.
US20070190078A1 (en) * 2003-10-14 2007-08-16 Mills Kingston H G Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders

Also Published As

Publication number Publication date
WO2006109285A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
EP1883416A4 (en) Compositions and methods for the prevention and treatment of conditions associated with inflammation
ZA200710598B (en) Treatment of inflammatory conditions
ZA200705827B (en) Indoles useful in the treatment of inflammation
EP1853295A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1940441A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
EP1948675A4 (en) Methods and compositions for the treatment of marfan syndrome and associated disorders
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
EP1996218A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL191537A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1720563A4 (en) Methods and compositions for the treatment of inflammation
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1912630A4 (en) Compositions and methods for the reduction of post-operative pain
ZA200707955B (en) Methods and pharmaceutical compositions for the treatment of neurological damage
HK1134032A1 (en) New combination for use in the treatment of inflammatory disorders
EP1981343A4 (en) Treatment of inflammatory disorders with triazole compounds
GB0604826D0 (en) The treatment of inflammatory disorders and pain
EP1773360A4 (en) Acute inflammatory condition treatment
EP1841442A4 (en) Treatment for autoimmune and inflammatory conditions
GB0507557D0 (en) Methods and compounds for the treatment of autoimmune deseases and chronic inflammatory conditions
GB0604822D0 (en) The treatment of inflammatory disorders and pain
ZA200710476B (en) Methods and compositions for the treatment of pain
GB0513413D0 (en) The treatment of inflammatory disorders and pain
GB0602857D0 (en) The treatment of sialorrhoea

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)